Foresite Capital Opportunity Management V, LLC has filed its 13F form on November 14, 2022 for Q3 2022 where it was disclosed a total value porftolio of $33.3 Million distributed in 9 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pardes Biosciences, Inc. with a value of $9.67M, Theseus Pharmaceuticals, Inc. with a value of $5.56M, Gemini Therapeutics, Inc. with a value of $3.99M, Compass Therapeutics, Inc. with a value of $3.54M, and Kinnate Biopharma Inc. with a value of $3.49M.

Examining the 13F form we can see an decrease of $6.37M in the current position value, from $39.7M to 33.3M.

Foresite Capital Opportunity Management V, LLC is based out at Larkspur, CA

Below you can find more details about Foresite Capital Opportunity Management V, LLC portfolio as well as his latest detailed transactions.

Portfolio value $33.3 Million
Healthcare: $31.6 Million
Consumer Defensive: $1.71 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 9
  • Current Value $33.3 Million
  • Prior Value $39.7 Million
  • Filing
  • Period Q3 2022
  • Filing Date November 14, 2022
  • Form Type 13F-HR
  • Activity in Q3 2022
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Foresite Capital Opportunity Management V, LLC Portfolio

Follow Foresite Capital Opportunity Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Opportunity Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Opportunity Management V, LLC with notifications on news.